Vista Pharmaceuticals Ltd.

BSE: 524711
Vista Pharmaceuticals Ltd. - pharma in Na, Telangana, India. FY 2026 financials and compliance.
CIN L24239TG1991PLC012264 Incorporated 25 January 1991 ROC Hyderabad HQ Na, Telangana, India
Active Listed - BSE: 524711 Public Limited Company pharma
Data last updated
Revenue · FY 2026
₹5.4 Cr
▼ 46.4% YoY
Computed EBITDA · FY 2026
-₹14.3 Cr
▼ 298.62% YoY
Net profit · FY 2026
-₹12.06 Cr
▼ 159.45% YoY
Authorised capital
₹15 Cr
Registered with MCA
Paid-up capital
₹12.31 Cr
Issued & subscribed
Open charges
₹17 Cr
Satisfied ₹16.08 Cr
Company age
35 yrs
Est. 1991
Last financials
Mar 2024
Balance sheet date

About Vista Pharmaceuticals Ltd.

Data last updated: 14 July 2026

Vista Pharmaceuticals Ltd. is a public limited company based in Na, Telangana, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 25 January 1991, the company has been in operation for over 35 years.

Registered with ROC Hyderabad under CIN L24239TG1991PLC012264. Listed on BSE: 524711.

Capital: an authorised share capital of ₹15 Cr and a paid-up capital of ₹12.31 Cr. It is led by directors including Umakanth Katta and Pavan Sathvik Gilaka.

Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: Na, Telangana.

As per BSE-filed standalone financials for FY 2026, the company reported a revenue of ₹5.4 Cr, a decline of 46.4% compared to the previous year. The net worth stands at ₹36.44 Cr (down 19.77% YoY). Total assets are valued at ₹55.08 Cr (down 8.64% YoY).

The company is associated with 1 brand - Vista Pharmaceuticals. As per MCA filings, the company has open charges of ₹17 Cr and satisfied charges of ₹16.08 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vistapharmaceuticals.com.

Company Details of Vista Pharmaceuticals Ltd.
CIN L24239TG1991PLC012264
Registration Number 012264
Incorporation Date 25 January 1991
ROC Hyderabad
Listing Status Listed (BSE: 524711)
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Key People
Murali Meraga Managing Director Pavan Sathvik Gilaka Whole-Time Director Dhananjaya Alli Whole-Time Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    vistapharmaceuticals.com
  • Social Media
    Locked
  • Registered Address
    Plot Nos.10 To 14 And 16 To 20 Apiic Industrial Estate Chityal Gop, Alaipalli, Na, Telangana, India – 508254
  • Industry
    Pharma, Drug Formulation & Development
Company report
Vista Pharmaceuticals Ltd. - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Vista Pharmaceuticals Ltd. report

Financials, compliance, directors, charges, ownership and filings for Vista Pharmaceuticals Ltd. in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Vista Pharmaceuticals Ltd.

Vista Pharmaceuticals Ltd. has one previous CIN (Corporate Identification Number): L24239AP1991PLC012264. The current CIN is L24239TG1991PLC012264, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L24239TG1991PLC012264 Current
L24239AP1991PLC012264 Previous

Associated Brands with Vista Pharmaceuticals Ltd.

Vista Pharmaceuticals Ltd. operates one associated brand: Vista Pharmaceuticals. These brands represent Vista Pharmaceuticals Ltd.'s diversified market presence and brand portfolio.

Brand Description Website
Vista Pharmaceuticals
Manufacturer of OTCs and generic prescription products vistapharmaceuticals.com

Business Activity of Vista Pharmaceuticals Ltd.

Vista Pharmaceuticals Ltd. is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Vista Pharmaceuticals Ltd.

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Vista Pharmaceuticals Ltd.

Vista Pharmaceuticals Ltd. is audited by A M REDDY & DR REDDY (ICAI peer reviewed, certificate valid till 2027-02-28) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
A M REDDY & DR REDDY (ICAI peer reviewed, certificate valid till 2027-02-28) FY 2026 Declaration of unmodified opinion

Board of Directors of Vista Pharmaceuticals Ltd.

Vista Pharmaceuticals Ltd. is currently managed by 9 directors, with 9 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Umakanth Katta
Also directs: Vipinam Avenues Llp, Nanyatha Estates Llp, Anuktha Nirvi Ventures Llp and 5 more
Director 13 Jul 2020 6 Years 1 Months Current
Pavan Sathvik Gilaka
Also directs: Mavone Infrastructure Private Limited
Whole-Time Director 14 Oct 2022 3 Years 10 Months Current
Murali Meraga
Also directs: Krisn Information Technologies Limited, C M K Globaltek Private Limited
Managing Director 14 Oct 2022 3 Years 10 Months Current
Mallem Hanumantha Rao Director 16 Sep 1993 32 Years 11 Months Current
Dhananjaya Alli Whole-Time Director 07 Sep 2015 11 Years 0 Months Current
Stanley Prabhakar Reddy Director 12 Aug 2016 10 Years 0 Months Current
Showing 6 of 9 current directors. View all directors

Financials of Vista Pharmaceuticals Ltd. FY 2026 filings available

Vista Pharmaceuticals Ltd. reported revenue of ₹5.4 Cr (down 46.4% YoY) for FY 2026.

Revenue · FY 2026
₹5.4 Cr ▼ 46.4%
Profit · FY 2026
-₹12.06 Cr ▼ 159.45%
Computed EBITDA · FY 2026
-₹14.3 Cr ▼ 298.62%
Revenue₹ Cr · Standalone02040FY 2019: ₹31 Cr31.1FY 2019FY 2020: ₹23 Cr · -26.8% YoY22.8-26.8%FY 2020FY 2021: ₹1 Cr · -94.4% YoY1.3-94.4%FY 2021FY 2022: ₹0 Cr · -68.8% YoY0.4-68.8%FY 2022FY 2023: ₹1 Cr · +154.4% YoY1+154.4%FY 2023FY 2024: ₹10 Cr · +925% YoY10.3+925%FY 2024FY 2025: ₹10 Cr · -2.1% YoY10.1-2.1%FY 2025FY 2026: ₹5 Cr · -46.4% YoY5.4-46.4%FY 2026
Net Profit₹ Cr · Standalone-15-10-505FY 2019: ₹1 Cr0.9FY 2019FY 2020: ₹4 Cr (loss) · -491.4% YoY-3.7FY 2020FY 2021: ₹2 Cr (loss) · +48.7% YoY-1.9FY 2021FY 2022: ₹1 Cr (loss) · +55.9% YoY-0.8FY 2022FY 2023: ₹6 Cr (loss) · -599.3% YoY-5.8FY 2023FY 2024: ₹5 Cr (loss) · +22.4% YoY-4.5FY 2024FY 2025: ₹5 Cr (loss) · -3% YoY-4.6FY 2025FY 2026: ₹12 Cr (loss) · -159.5% YoY-12.1FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year024Q1'25: ₹2 Cr1.8Q1'25Q2'25: ₹2 Cr2.5Q2'25Q3'25: ₹3 Cr2.6Q3'25Q4'25: ₹3 Cr3.2Q4'25Q1'26: ₹2 Cr · -15.4% YoY1.5-15.4%Q1'26Q2'26: ₹1 Cr · -41.4% YoY1.5-41.4%Q2'26Q3'26: ₹2 Cr · -5.4% YoY2.4-5.4%Q3'26Q4'26: ₹0 Cr · -100% YoY0-100%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Revenue from Operations ₹5.4 Cr ₹10.07 Cr ₹10.29 Cr ₹1 Cr ₹39.46 Lakh ₹1.27 Cr ₹22.76 Cr ₹31.07 Cr
Other Income ₹31.5 Lakh ₹44.06 Lakh ₹33.34 Lakh ₹28.55 Lakh ₹16.57 Lakh ₹31.85 Lakh ₹3.75 Cr ₹2.95 Cr
Total Income ₹5.71 Cr ₹10.52 Cr ₹10.62 Cr ₹1.29 Cr ₹56.03 Lakh ₹1.58 Cr ₹26.51 Cr ₹34.02 Cr
Cost of Materials Consumed ₹5.22 Cr ₹7.9 Cr ₹8.88 Cr ₹1.23 Cr ₹36.66 Lakh ₹73.02 Lakh ₹22.9 Cr ₹26.81 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹0 ₹44.78 Lakh ₹77,000 ₹0 ₹0 ₹0 ₹1.04 Cr -₹1.4 Cr
Employee Benefit Expense ₹2.2 Cr ₹2 Cr ₹1.79 Cr ₹58.19 Lakh ₹57.48 Lakh ₹1.15 Cr ₹1.49 Cr ₹1.36 Cr
Finance Costs ₹1.1 Cr ₹96.4 Lakh ₹1.22 Cr ₹1.21 Cr ₹89.98 Lakh ₹1.55 Cr ₹1.54 Cr ₹1.67 Cr
Depreciation & Amortisation ₹74.89 Lakh ₹73.81 Lakh ₹71.97 Lakh ₹1.57 Cr ₹61.62 Lakh ₹72.77 Lakh ₹1.35 Cr ₹1.36 Cr
Other Expenses ₹12.59 Cr ₹3.75 Cr ₹3.17 Cr ₹1.41 Cr ₹66.37 Lakh ₹1.11 Cr ₹2.13 Cr ₹3.06 Cr
Total Expenses ₹21.87 Cr ₹15.81 Cr ₹15.8 Cr ₹6.01 Cr ₹3.12 Cr ₹5.27 Cr ₹30.44 Cr ₹32.87 Cr
Profit Before Exceptional Items & Tax -₹16.15 Cr -₹5.29 Cr -₹5.18 Cr -₹4.72 Cr -₹2.56 Cr -₹3.69 Cr -₹3.94 Cr ₹1.15 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax -₹16.15 Cr -₹5.29 Cr -₹5.18 Cr -₹4.72 Cr -₹2.56 Cr -₹3.69 Cr -₹3.94 Cr ₹1.15 Cr
Total Tax Expense -₹4.09 Cr -₹64.11 Lakh -₹66.54 Lakh ₹2.15 Cr -₹1.73 Cr -₹1.8 Cr -₹25.89 Lakh ₹20.78 Lakh
Net Profit -₹12.06 Cr -₹4.65 Cr -₹4.51 Cr -₹5.82 Cr -₹83.18 Lakh -₹1.89 Cr -₹3.68 Cr ₹93.94 Lakh
Other Comprehensive Income ₹45,000 -₹2.11 Lakh ₹29,000 -₹1.42 Lakh ₹0 ₹0 ₹0 ₹0
Total Comprehensive Income -₹12.06 Cr -₹4.67 Cr -₹4.51 Cr -₹5.83 Cr -₹83.18 Lakh -₹1.89 Cr -₹3.68 Cr ₹93.94 Lakh
EBITDA (computed) -₹14.3 Cr -₹3.59 Cr -₹3.24 Cr -₹1.94 Cr -₹1.04 Cr -₹1.41 Cr -₹1.05 Cr ₹4.19 Cr
Basic EPS ₹-1.96 ₹-0.79 ₹-1.03 ₹-1.58 ₹-0.24 ₹-0.63 ₹-1.22 ₹0.31
Diluted EPS ₹-1.96 ₹-0.79 ₹-0.74 ₹-0.92 ₹-0.24 ₹-0.63 ₹-1.22 ₹0.31
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Total Assets ₹55.08 Cr ₹60.29 Cr ₹57.98 Cr ₹56.53 Cr ₹55.59 Cr ₹50.85 Cr ₹51.12 Cr ₹52.76 Cr
Non-current Assets ₹39.72 Cr ₹45.53 Cr ₹34.58 Cr ₹35.62 Cr ₹40.24 Cr ₹35.62 Cr ₹29.94 Cr ₹29.31 Cr
Current Assets ₹15.36 Cr ₹14.76 Cr ₹23.4 Cr ₹20.92 Cr ₹15.34 Cr ₹15.24 Cr ₹21.19 Cr ₹23.45 Cr
Property, Plant & Equipment ₹8.71 Cr ₹9.15 Cr ₹9.77 Cr ₹10.19 Cr ₹9.78 Cr ₹10.38 Cr ₹11.11 Cr ₹12.45 Cr
Inventories ₹11.01 Cr ₹8.22 Cr ₹6.79 Cr ₹9.28 Cr ₹9.33 Cr ₹9.68 Cr ₹9.68 Cr ₹11.25 Cr
Trade Receivables ₹31.66 Lakh ₹3.39 Cr ₹14.28 Cr ₹6.27 Cr ₹2.57 Cr ₹2.17 Cr ₹10.28 Cr ₹8.35 Cr
Cash & Equivalents ₹10.7 Lakh ₹1.05 Lakh ₹9.44 Lakh ₹0 ₹7.19 Lakh ₹14.01 Lakh ₹22.52 Lakh ₹86.77 Lakh
Equity (Net Worth) ₹36.44 Cr ₹45.42 Cr ₹40.46 Cr ₹36.54 Cr ₹35.45 Cr ₹32.85 Cr ₹29.64 Cr ₹35.8 Cr
Equity Share Capital ₹12.31 Cr ₹12.31 Cr ₹9.43 Cr ₹7.36 Cr ₹7.36 Cr ₹7.36 Cr ₹6.07 Cr ₹6.07 Cr
Borrowings (Non-current) ₹1.84 Cr ₹2.38 Cr ₹2.93 Cr ₹5.18 Cr ₹15.95 Cr ₹8.69 Cr ₹5.51 Cr ₹5.96 Cr
Borrowings (Current) ₹8.14 Cr ₹5.02 Cr ₹5.03 Cr ₹4.65 Cr ₹99.98 Lakh ₹6.28 Cr ₹9.96 Cr ₹5.21 Cr
Total Debt (computed) ₹9.99 Cr ₹7.4 Cr ₹7.96 Cr ₹9.83 Cr ₹16.95 Cr ₹14.98 Cr ₹15.47 Cr ₹11.17 Cr
Current Liabilities ₹16.65 Cr ₹12.37 Cr ₹14.49 Cr ₹14.76 Cr ₹4.12 Cr ₹9.25 Cr ₹15.92 Cr ₹10.95 Cr
Total Liabilities ₹18.64 Cr ₹14.87 Cr ₹17.52 Cr ₹19.99 Cr ₹20.14 Cr ₹18.01 Cr ₹21.48 Cr ₹16.96 Cr
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow -₹4.4 Cr -₹6.98 Cr -₹4.92 Cr -₹1.72 Cr -₹1.13 Cr
Investing Cash Flow -₹78.21 Lakh -₹44 Lakh -₹78.99 Lakh -₹1.27 Cr -₹1.43 Lakh
Financing Cash Flow ₹4.56 Cr ₹8.06 Cr ₹5.59 Cr ₹2.99 Cr ₹1.07 Cr
Capital Expenditure ₹78.21 Lakh ₹12.39 Lakh ₹78.99 Lakh ₹1.27 Cr ₹1.43 Lakh
Free Cash Flow (computed) -₹5.18 Cr -₹7.11 Cr -₹5.71 Cr -₹2.99 Cr -₹1.14 Cr
Dividends Paid ₹0 ₹0 ₹0 ₹0 ₹0
Net Change in Cash -₹62.62 Lakh ₹63.89 Lakh -₹11.28 Lakh ₹7,000 -₹6.81 Lakh
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25
Revenue from Operations ₹0 ₹2.42 Cr ₹1.46 Cr ₹1.52 Cr ₹3.23 Cr ₹2.56 Cr ₹2.49 Cr ₹1.8 Cr
Other Income ₹3.28 Lakh ₹8.98 Lakh ₹19.24 Lakh ₹0 ₹24.06 Lakh ₹12.19 Lakh ₹70,100 ₹7.11 Lakh
Total Income ₹3.28 Lakh ₹2.51 Cr ₹1.65 Cr ₹1.52 Cr ₹3.47 Cr ₹2.68 Cr ₹2.5 Cr ₹1.87 Cr
Cost of Materials Consumed ₹0 ₹2.26 Cr ₹1.46 Cr ₹1.5 Cr ₹2.69 Cr ₹2.05 Cr ₹1.55 Cr ₹1.6 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹0 ₹0 ₹0 ₹0 ₹0 ₹44.78 Lakh ₹0 ₹0
Employee Benefit Expense ₹49.87 Lakh ₹58.98 Lakh ₹56.8 Lakh ₹54.24 Lakh ₹56.02 Lakh ₹51.54 Lakh ₹47.87 Lakh ₹44.97 Lakh
Finance Costs ₹55.27 Lakh ₹17.74 Lakh ₹17.78 Lakh ₹19.3 Lakh ₹20.63 Lakh ₹22.26 Lakh ₹25.26 Lakh ₹28.25 Lakh
Depreciation & Amortisation ₹18.72 Lakh ₹18.71 Lakh ₹19.87 Lakh ₹17.58 Lakh ₹18.46 Lakh ₹18.69 Lakh ₹18.34 Lakh ₹18.32 Lakh
Other Expenses ₹6.56 Cr ₹2.57 Cr ₹2.87 Cr ₹58.92 Lakh ₹88.71 Lakh ₹1.06 Cr ₹1.29 Cr ₹51.93 Lakh
Total Expenses ₹7.8 Cr ₹5.79 Cr ₹5.28 Cr ₹3 Cr ₹4.53 Cr ₹4.48 Cr ₹3.75 Cr ₹3.04 Cr
Profit Before Exceptional Items & Tax -₹7.77 Cr -₹3.28 Cr -₹3.62 Cr -₹1.48 Cr -₹1.06 Cr -₹1.8 Cr -₹1.25 Cr -₹1.17 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax -₹7.77 Cr -₹3.28 Cr -₹3.62 Cr -₹1.48 Cr -₹1.06 Cr -₹1.8 Cr -₹1.25 Cr -₹1.17 Cr
Total Tax Expense -₹1.91 Cr -₹96.1 Lakh -₹1.03 Cr -₹18.97 Lakh ₹43.36 Lakh -₹48.21 Lakh -₹27.83 Lakh -₹31.43 Lakh
Net Profit -₹5.86 Cr -₹2.32 Cr -₹2.59 Cr -₹1.29 Cr -₹1.5 Cr -₹1.32 Cr -₹97.37 Lakh -₹85.7 Lakh
Other Comprehensive Income -₹2.93 Lakh ₹1.33 Lakh ₹58,000 ₹1.47 Lakh -₹1.24 Lakh ₹2.63 Lakh ₹0 ₹41,000
Total Comprehensive Income -₹5.89 Cr -₹2.31 Cr -₹2.58 Cr -₹1.28 Cr -₹1.51 Cr -₹1.3 Cr -₹97.37 Lakh -₹85.29 Lakh
EBITDA (computed) -₹7.03 Cr -₹2.92 Cr -₹3.25 Cr -₹1.11 Cr -₹67.11 Lakh -₹1.39 Cr -₹81.61 Lakh -₹70.56 Lakh
Basic EPS ₹-0.91 ₹-0.41 ₹-0.42 ₹-0.22 ₹-0.26 ₹-0.07 ₹0.00 ₹-0.15
Diluted EPS ₹-0.91 ₹-0.41 ₹-0.44 ₹-0.22 ₹-0.26 ₹-0.07 ₹0.00 ₹-0.15
Latest 8 quarters shown.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Vista Pharmaceuticals Ltd.. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Vista Pharmaceuticals Ltd.

As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 21.19%, domestic institutional investors hold 0.02%, retail and other public shareholders hold 78.79% of Vista Pharmaceuticals Ltd.. The company had 14,154 shareholders on record.

Promoters: 21.19%DII (Domestic Institutional): 0.02%Retail & Others: 78.79%
Mar 2026
QUARTER
21.19% Promoters
0.02% DII (Domestic Institutional)
78.79% Retail & Others
Promoter holding - history
Now 21.19% · Mar 2026High 30.49% · Jun 2023Low 21.19% · Jun 2024
20%23%26%29%32%Jun 2023Dec 2023Jun 2024Dec 2024Jun 2025Dec 2025Jun 2023: 30.49%Sep 2023: 29.51%Dec 2023: 27.81%Mar 2024: 27.81%Jun 2024: 21.19%Sep 2024: 21.19%Dec 2024: 21.19%Mar 2025: 21.19%Jun 2025: 21.19%Sep 2025: 21.19%Dec 2025: 21.19%Mar 2026: 21.19%30.49%21.19%21.19%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters21.19%21.19%21.19%21.19%21.19%21.19%
Public78.81%78.81%78.81%78.81%78.81%78.81%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024
Promoters21.19%21.19%27.81%
Public78.81%78.81%72.19%
Promoter change (YoY, %pts)+0.00-6.62-

Charges & Borrowings of Vista Pharmaceuticals Ltd.

Open charges
₹17 Cr
Satisfied charges
₹16.08 Cr
Breakdown by lending institutions
Vijaya Bank₹17.00 Cr
Latest charge details
DateLenderAmountStatus
23 Feb 2017 Vijaya Bank ₹17 Cr Open
25 Jun 2015 State Bank of India ₹8 Cr Satisfied
02 May 2014 Allahabad Bank ₹4 Cr Satisfied
16 Oct 1995 State Bank of Hyderabad ₹1.1 Cr Satisfied
12 Sep 1994 State Bank of Hyderabad ₹2.08 Cr Satisfied

Total charge records: 6 View all charges

Employees and EPFO Compliance at Vista Pharmaceuticals Ltd.

View historical data on people associated with Vista Pharmaceuticals Ltd., including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Vista Pharmaceuticals Ltd.

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Vista Pharmaceuticals Ltd.

Premium access

GST registrations and filing compliance for Vista Pharmaceuticals Ltd.

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Vista Pharmaceuticals Ltd.

Premium access

Credit ratings, litigation, and regulatory alerts for Vista Pharmaceuticals Ltd.

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Vista Pharmaceuticals Ltd.

Premium access

MSME payment history for Vista Pharmaceuticals Ltd.

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Vista Pharmaceuticals Ltd.

Premium access

Corporate group structure for Vista Pharmaceuticals Ltd.

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Vista Pharmaceuticals Ltd.

Premium access

MCA filings and documents for Vista Pharmaceuticals Ltd.

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Vista Pharmaceuticals Ltd.

Activity
30 Sep 2024
Vista Pharmaceuticals Ltd. last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Directors
03 May 2024
Barkha Jain was appointed as a Company Secretary on 03 May 2024 & has been associated with this company since 2 years 4 months.
Activity
31 Mar 2024
Vista Pharmaceuticals Ltd. has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Directors
14 Oct 2022
Pavan Sathvik Gilaka was appointed as a Whole-time director on 14 Oct 2022 & has been associated with this company since 3 years 10 months.
Directors
14 Oct 2022
Murali Meraga was appointed as a Managing Director on 14 Oct 2022 & has been associated with this company since 3 years 10 months.
Directors
13 Jul 2020
Umakanth Katta was appointed as a Director on 13 Jul 2020 & has been associated with this company since 6 years 1 month.

Recent News on Vista Pharmaceuticals Ltd.

Vista Pharma Submits ANDA for Cardiac Drug
11 May 2018 · Medicalbuyer

Frequently Asked Questions about Vista Pharmaceuticals Ltd.

Vista Pharmaceuticals Ltd. is an active public limited company in the pharma sector based in Na, Telangana, India. It was incorporated on 25 January 1991 (35+ years old) and is registered under CIN L24239TG1991PLC012264. Listed on BSE: 524711.

Vista Pharmaceuticals Ltd. reported revenue of ₹5.4 Cr for FY 2026 (down 46.4% YoY) based on standalone BSE filings.

The current directors of Vista Pharmaceuticals Ltd. are:

The primary industry of Vista Pharmaceuticals Ltd. is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Yes. Vista Pharmaceuticals Ltd. is listed on BSE with code 524711.

Vista Pharmaceuticals Ltd. can be reached at the registered office: Plot Nos.10 To 14 And 16 To 20 Apiic Industrial Estate Chityal Gop, Alaipalli, Na, Telangana, India – 508254, or through the website vistapharmaceuticals.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available